Saniona AB
STO:SANION

Watchlist Manager
Saniona AB Logo
Saniona AB
STO:SANION
Watchlist
Price: 8.12 SEK 0.62% Market Closed
Market Cap: 903.3m SEK
Have any thoughts about
Saniona AB?
Write Note

Relative Value

The Relative Value of one SANION stock under the Base Case scenario is 3.56 SEK. Compared to the current market price of 8.12 SEK, Saniona AB is Overvalued by 56%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SANION Relative Value
Base Case
3.56 SEK
Overvaluation 56%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
79
vs Industry
34
Median 3Y
18.3
Median 5Y
47.9
Industry
7.6
vs History
vs Industry
Median 3Y
-2.4
Median 5Y
-4.5
Industry
22.1
vs History
vs Industry
Median 3Y
-2.2
Median 5Y
-4.8
Industry
21.9
vs History
vs Industry
Median 3Y
-1.8
Median 5Y
-3.9
Industry
23.4
vs History
12
vs Industry
6
Median 3Y
4.5
Median 5Y
3.7
Industry
2.5
vs History
71
vs Industry
29
Median 3Y
17.4
Median 5Y
33.4
Industry
7.5
vs History
vs Industry
Median 3Y
-5.4
Median 5Y
-7.7
Industry
9.3
vs History
vs Industry
Median 3Y
-2.8
Median 5Y
-4.3
Industry
4.2
vs History
vs Industry
Median 3Y
-2.4
Median 5Y
-4.3
Industry
4
vs History
vs Industry
Median 3Y
-2.2
Median 5Y
-4
Industry
5.9
vs History
vs Industry
Median 3Y
-2.1
Median 5Y
-3.9
Industry
3.9
vs History
31
vs Industry
17
Median 3Y
7.7
Median 5Y
7.6
Industry
4.5

Multiples Across Competitors

SANION Competitors Multiples
Saniona AB Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DK
Saniona AB
STO:SANION
903.3m SEK 36.3 -11 -13.4 -13.4
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 039 618.2 -180 796.7 -219 544.7 -217 039.4
US
Abbvie Inc
NYSE:ABBV
310.3B USD 5.6 61.1 15.2 23.4
US
Amgen Inc
NASDAQ:AMGN
141.6B USD 4.4 33.5 16 30.4
US
Gilead Sciences Inc
NASDAQ:GILD
115.3B USD 4.1 915.4 10.2 10.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
102.4B USD 9.6 -213.4 21 22.1
US
Epizyme Inc
F:EPE
94.1B EUR 1 852 -472.6 -514.6 -500.9
AU
CSL Ltd
ASX:CSL
133.7B AUD 5.6 31.6 19.6 24.4
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.3B USD 5.6 16.6 15.1 16.7
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.7 -58.8 -53
NL
argenx SE
XBRU:ARGX
36.2B EUR 19.4 -136.1 -110 -80.2
P/S Multiple
Revenue Growth P/S to Growth
DK
Saniona AB
STO:SANION
Average P/S: 3 458 325.3
36.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
38 039 618.2
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.6
20%
0.3
US
Amgen Inc
NASDAQ:AMGN
4.4
26%
0.2
US
Gilead Sciences Inc
NASDAQ:GILD
4.1
10%
0.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.6
34%
0.3
US
E
Epizyme Inc
F:EPE
1 852
N/A N/A
AU
CSL Ltd
ASX:CSL
5.6
23%
0.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.6
23%
0.2
US
S
Seagen Inc
F:SGT
17.8
118%
0.2
NL
argenx SE
XBRU:ARGX
19.4
220%
0.1
P/E Multiple
Earnings Growth P/E to Growth
DK
Saniona AB
STO:SANION
Average P/E: 211.6
Negative Multiple: -11
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -180 796.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
61.1
413%
0.1
US
Amgen Inc
NASDAQ:AMGN
33.5
73%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
915.4
77%
11.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -213.4
48%
N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472.6 N/A N/A
AU
CSL Ltd
ASX:CSL
31.6
65%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.6
44%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.7 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -136.1 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
DK
Saniona AB
STO:SANION
Average EV/EBITDA: 16.2
Negative Multiple: -13.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 544.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.2
29%
0.5
US
Amgen Inc
NASDAQ:AMGN
16
62%
0.3
US
Gilead Sciences Inc
NASDAQ:GILD
10.2
16%
0.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
21
43%
0.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514.6 N/A N/A
AU
CSL Ltd
ASX:CSL
19.6
42%
0.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.1
35%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.8 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -110 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
DK
Saniona AB
STO:SANION
Average EV/EBIT: 21.2
Negative Multiple: -13.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -217 039.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.4
90%
0.3
US
Amgen Inc
NASDAQ:AMGN
30.4
90%
0.3
US
Gilead Sciences Inc
NASDAQ:GILD
10.2
32%
0.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.1
45%
0.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -500.9 N/A N/A
AU
CSL Ltd
ASX:CSL
24.4
54%
0.4
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.7
42%
0.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -53 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -80.2 N/A N/A

See Also

Discover More
Back to Top